Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
$1.08
+4.9%		$1.09
$0.70
▼
$18.10
$3.49M2.4957,216 shs43,692 shs
Ainos, Inc. stock logo
AIMD
Ainos
$1.49
-2.6%		$1.78
$1.26
▼
$4.44
$11.00M2.46219,490 shs34,735 shs
Ebang International Holdings Inc. stock logo
EBON
Ebang International
$1.93
+1.0%		$2.11
$1.61
▼
$5.90
$12.83M33,869 shs5,758 shs
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
$2.92
+4.3%		$3.57
$0.04
▼
$8.94
$5.39M2.0432.22 million shs106,732 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
0.00%+44.00%-4.42%+19.89%-48.82%
Ainos, Inc. stock logo
AIMD
Ainos
0.00%+12.03%-21.99%-12.35%-54.29%
Ebang International Holdings Inc. stock logo
EBON
Ebang International
0.00%-1.53%-9.98%-16.27%-53.38%
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
+4.29%+11.88%-20.22%-22.55%-72.06%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
$1.08
+4.9%		$1.09
$0.70
▼
$18.10
$3.49M2.4957,216 shs43,692 shs
Ainos, Inc. stock logo
AIMD
Ainos
$1.49
-2.6%		$1.78
$1.26
▼
$4.44
$11.00M2.46219,490 shs34,735 shs
Ebang International Holdings Inc. stock logo
EBON
Ebang International
$1.93
+1.0%		$2.11
$1.61
▼
$5.90
$12.83M33,869 shs5,758 shs
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
$2.92
+4.3%		$3.57
$0.04
▼
$8.94
$5.39M2.0432.22 million shs106,732 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
0.00%+44.00%-4.42%+19.89%-48.82%
Ainos, Inc. stock logo
AIMD
Ainos
0.00%+12.03%-21.99%-12.35%-54.29%
Ebang International Holdings Inc. stock logo
EBON
Ebang International
0.00%-1.53%-9.98%-16.27%-53.38%
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
+4.29%+11.88%-20.22%-22.55%-72.06%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
1.00
Sell$5.77434.26% Upside
Ainos, Inc. stock logo
AIMD
Ainos
1.00
SellN/AN/A
Ebang International Holdings Inc. stock logo
EBON
Ebang International
1.00
SellN/AN/A
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest AGMH, EBON, AIMD, and TNFA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/13/2026
Ebang International Holdings Inc. stock logo
EBON
Ebang International
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
6/26/2026
Ebang International Holdings Inc. stock logo
EBON
Ebang International
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
5/26/2026
Ainos, Inc. stock logo
AIMD
Ainos
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
5/22/2026
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
(Data available from 8/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
$32.04M0.11$6.35 per share0.17$41.48 per share0.03
Ainos, Inc. stock logo
AIMD
Ainos
$13.60K808.98N/AN/A$0.44 per share3.39
Ebang International Holdings Inc. stock logo
EBON
Ebang International
$6.54M1.93N/AN/A$37.44 per share0.05
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
N/AN/AN/AN/A$286.76 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
$3.12MN/AN/AN/AN/AN/AN/AN/AN/A
Ainos, Inc. stock logo
AIMD
Ainos
-$14.77M-$2.52N/AN/AN/A-11,912.10%-217.50%-67.87%N/A
Ebang International Holdings Inc. stock logo
EBON
Ebang International
-$14.09MN/AN/AN/AN/AN/AN/AN/AN/A
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
-$23.36M-$231.00N/AN/AN/AN/A-69.21%-33.98%N/A

Latest AGMH, EBON, AIMD, and TNFA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/3/2026Q2 2026
Ainos, Inc. stock logo
AIMD
Ainos
N/A-$0.62N/A-$0.62N/A$0.15 million
5/13/2026Q1 2026
Ainos, Inc. stock logo
AIMD
Ainos
N/A-$0.41N/A-$0.41N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
N/AN/AN/AN/AN/A
Ainos, Inc. stock logo
AIMD
Ainos
N/AN/AN/AN/AN/A
Ebang International Holdings Inc. stock logo
EBON
Ebang International
N/AN/AN/AN/AN/A
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
N/AN/AN/A
Ainos, Inc. stock logo
AIMD
Ainos
N/A
0.13
0.50
Ebang International Holdings Inc. stock logo
EBON
Ebang International
N/A
27.31
26.85
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
N/A
0.93
0.93

Institutional Ownership

CompanyInstitutional Ownership
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
N/A
Ainos, Inc. stock logo
AIMD
Ainos
N/A
Ebang International Holdings Inc. stock logo
EBON
Ebang International
1.15%
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
9.64%

Insider Ownership

CompanyInsider Ownership
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
34.91%
Ainos, Inc. stock logo
AIMD
Ainos
9.79%
Ebang International Holdings Inc. stock logo
EBON
Ebang International
25.40%
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
0.45%
CompanyEmployeesShares OutstandingFree FloatOptionable
AGM Group Holdings Inc. stock logo
AGMH
AGM Group
203.23 million2.10 millionNot Optionable
Ainos, Inc. stock logo
AIMD
Ainos
407.38 million6.66 millionNot Optionable
Ebang International Holdings Inc. stock logo
EBON
Ebang International
2606.54 million4.88 millionNo Data
TNF Pharmaceuticals, Inc. stock logo
TNFA
TNF Pharmaceuticals
61.85 million1.84 millionN/A

Recent News About These Companies

TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol “TNFA” Effective Before Market Open Today
June 23, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20240724213342/en/TNF-Pharmaceuticals-Formerly-MyMD-Pharmaceuticals-Begins-Trading-Under-New-Nasdaq-Stock-Symbol-TNFA-Effective-Before-Market-Open-Today
Tnf Pharmaceuticals: A Corporate Pivot Under Scrutiny
February 24, 2026  |  newscase.comN
Why did QCLS stock surge over 60% today?
December 4, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/why-did-qcls-stock-surge-over-60-today/ar-AA1RJkpU
Rheumatoid Arthritis Market to Surge by 2034 as Next-Generation Biologics and JAK Inhibitors Gain Traction | DelveInsight
November 5, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/rheumatoid-arthritis-market-surge-2034-223100043.html
Forward Therapeutics Announces First Participants Dosed in Phase 1 Healthy Volunteer Study of FT2109, a Next-Generation TNF Signaling Inhibitor
October 30, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/forward-therapeutics-announces-first-participants-dosed-in-phase-1-healthy-volunteer-study-of-ft2109-a-next-generation-tnf-signaling-inhibitor-1035455199
Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol "QCLS"
September 26, 2025  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2025/09/25/10260815.htm
TNF Pharmaceuticals changes name to Q/C Technologies
September 25, 2025  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/tnf-pharmaceuticals-changes-name-to-q-c-technologies/ar-AA1NdUJ1
TNF Pharmaceuticals stock soars after strategic pivot to quantum computing
September 25, 2025  |  investing.comhttps://www.investing.com/news/stock-market-news/tnf-pharmaceuticals-stock-soars-after-strategic-pivot-to-quantum-computing-93CH-4253533
TNF Pharmaceuticals regains compliance with Nasdaq
September 17, 2025  |  msn.comhttps://www.msn.com/en-us/money/topstocks/tnf-pharmaceuticals-regains-compliance-with-nasdaq/ar-AA1MKHkG
TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 17, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250917806538/en/tnf-pharmaceuticals-regains-compliance-with-nasdaq-minimum-bid-price-requirement/
TNF Pharmaceuticals Announces Closing of $7 Million Private Placement
September 4, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250904261260/en/TNF-Pharmaceuticals-Announces-Closing-of-7-Million-Private-Placement/
TNF Pharmaceuticals stock climbs after securing exclusive crypto computing rights
September 2, 2025  |  investing.comhttps://www.investing.com/news/stock-market-news/tnf-pharmaceuticals-stock-climbs-after-securing-exclusive-crypto-computing-rights-93CH-4219545
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
September 2, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250902025594/en/pharmacyte-biotech-inc.-increases-stake-in-tnf-pharmaceuticals-around-recent-license-for-breakthrough-light-speed-computing-platform-for-use-in-cryptocurrency-applications/
TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance
August 29, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/tnf-pharmaceuticals-announces-reverse-stock-131500170.html
TNF Pharmaceuticals announces improved financial position
August 20, 2025  |  msn.comhttps://www.msn.com/en-us/money/news/tnf-pharmaceuticals-announces-improved-financial-position/ar-AA1KQ0Mv
TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation
August 19, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250819482046/en/tnf-pharmaceuticals-strengthens-financial-position-for-growth-and-value-creation/
TNF Pharmaceuticals Inc Ordinary Shares TNFA - Morningstar
July 11, 2025  |  morningstar.comM
Akers files written objection to her Judicial Investigative admonishment
July 4, 2025  |  wvgazettemail.comW
Dorothy Marillyn Akers
July 2, 2025  |  chattanoogan.comC
Newly-signed running back Cam Akers has already changed his jersey number
June 30, 2025  |  msn.comhttps://www.msn.com/en-us/sports/nfl/newly-signed-running-back-cam-akers-has-already-changed-his-jersey-number/ar-AA1HHb8f

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGM Group stock logo

AGM Group NASDAQ:AGMH

$1.08 +0.05 (+4.85%)
Closing price 08/7/2026 04:00 PM Eastern
Extended Trading
$1.05 -0.03 (-2.50%)
As of 08/7/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AGM Group Holdings Inc. operates as a technology company, engages in the research and development of blockchain-oriented ASIC chip in Singapore, Hong Kong, and China. The company offers MetaTrader 5, a futures trading solution; and foreign exchange trading system that provides services to financial institutions. It also engages in the research and development, manufacture, and sales of technology hardware. In addition, the company sells cryptocurrency mining machine and standardized computing equipment, and technical support plans, as well as delivers fintech software services. AGM Group Holdings Inc. was incorporated in 2015 and is based in Wan Chai, Hong Kong.

Ainos stock logo

Ainos NASDAQ:AIMD

$1.49 -0.04 (-2.61%)
Closing price 08/7/2026 03:59 PM Eastern
Extended Trading
$1.48 -0.01 (-0.67%)
As of 08/7/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

Ebang International stock logo

Ebang International NASDAQ:EBON

$1.93 +0.02 (+1.05%)
Closing price 08/7/2026 03:58 PM Eastern
Extended Trading
$1.97 +0.04 (+2.02%)
As of 08/7/2026 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ebang International Holdings Inc., through its subsidiaries, engages in the research, design, and development of application-specific integrated circuit chips and manufacture of Bitcoin mining machines under the Ebit brand in Singapore, Hong Kong, Australia, the Bahamas, and internationally. It also provides mining machine hosting services; and engages in the development of proprietary cryptocurrency exchange platform. In addition, the company offers fiber-optic communication access devices, including multiprotocol label switching fiber-optic access network devices, multi-service access platform integrated business access devices, and wavelength-division multiplexing fiber-optic devices; and enterprise convergent terminal products, which consists gigabit passive optical network, Fiber to the Room products, passive optical network converged gateways, enterprise cloud gateway devices, industrial Internet of Things access devices, and business enterprise smart wireless access devices. It serves the blockchain and telecommunications industries. The company also operates a cross-border payment and foreign exchange platform. It sells its blockchain products directly, as well as through its website; and telecommunication products under the EBANG brand name primarily through supplier contracts. The company was incorporated in 2018 and is headquartered in Hangzhou, China.

TNF Pharmaceuticals stock logo

TNF Pharmaceuticals NASDAQ:TNFA

$2.92 +0.12 (+4.29%)
As of 08/7/2026

TNF Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company. It focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas